Young People and Illness Management and Recovery (IMR)

NCT04778085 | Terminated

• 1 other identifier: 20/09657
• Study Type: observational
• Target: 10
• Locations: 1 country
• Sites: 1

Brief Summary

The study is a combined clinical patient outcome study and a health-services research sub-study. Illness management and recovery (IMR) constitutes an evidence-based practice with 11 modules focusing on personal recovery developed for adults with severe mental health illnesses. IMR can be offered in groups or individually, once a week for 10-12 months. Little is known about how young people experience the utility of IMR treatment groups in child and adolescent mental health outpatient clinics. The primary aim is to explore in-depth how the participants experience the utility of the IMR approach. The health research sub-study will provide new insights into the IMR implementation process in outpatient clinics for adolescents.

Conditions

Psychosis; Bipolar Disorder; Other Diagnoses and Conditions

Keywords

Psychosis

Outcome Measures

Primary Outcomes (3)

• Focus-group interview aiming to explore the significance of the participant's own understanding of and knowledge about the disorder.

  Focus-group interviews when the treatment group has come to an end aimed at exploring different perspectives on IMR treatment.

  End of treatment group, on average 11 months.

• Focus-group interview aiming to explore the impact of the IMR treatment on dealing with everyday life.

  Focus-group interviews when the treatment group has come to an end aimed at exploring different perspectives on IMR treatment.

  End of treatment group, on average 11 months.

• Focus-group interview aiming to explore the importance of meeting other young people in the same situation.

  Focus-group interviews when the treatment group has come to an end aimed at exploring different perspectives on IMR treatment.

  End of treatment group, on average 11 months.

Secondary Outcomes (4)

• The Illness Management and Recovery Scale (IMRS)

  Baseline (0 months), 6 and 12 months.

• The Illness Management Fidelity Scale

  Baseline (0 months), 6 and 12 months.

• General Organizational Index

  Baseline (0 months), 6 and 12 months.

• Attendance registration

  Baseline (0 months), 3, 6, 9 and 12 months.

Other Outcomes (1)

• Mapping the total number of patients identified receiving a psychosis-related diagnosis within the categories F 20-39 (ICD 10) for the years 2021-2023.

  End of treatment group, on average of 11 months.

Study Arms (2)

IMR patients

Patients from outpatient clinics receiving IMR from trained IMR therapists and IMR therapists in training.

Behavioral: Illness management and recovery

IMR therapists and other staff

Clinic leaders, IMR therapists and other staff participating in semi-structured individual or group interviews.

Other: Semi-structured interviews

Interventions

Illness management and recovery BEHAVIORAL

Treatment given in groups, weekly for 10-12 months.

Also known as: IMR

IMR patients

Semi-structured interviews OTHER

Semi-structured individual or group interviews conducted three times with staff on each participating outpatient clinic.

IMR therapists and other staff

Eligibility Criteria

• Age: 13 Years - 17 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17)
• Sampling Method: Non-Probability Sample

Study Population

Patients between 13-17 years of age suffering from or having symptoms of psychosis or bipolar disorders, and who participate in an IMR treatment group at one of the 4 (out of 7) outpatient clinics in the hospitals catchment area, and who are able to give informed consent. Up to 8 inpatients or previous inpatients between 13- 17 years of age suffering from various diagnoses will be invited to participate in a pilot focus-group interview. Trained clinicians and clinicians in training contribute to the implementation in the outpatient clinics together with clinic leaders and other clinicians.

You may qualify if:

• Outpatient units:
• Included in the IMR group in one of the outpatient clinics
• Able to give informed consent
• Inpatient unit (focus group):
• years of age
• Current or previous patient
• Able to understand and speak Norwegian
• Able to give informed consent

You may not qualify if:

• Younger than 13 years
• Mental retardation
• Manic phase
• IMR therapist leading IMR treatment groups in one of the participating outpatient clinics
• Trained or training in IMR
• Employed at the Department for Child and Adolescent Mental Health Services at Akershus University Hospital.
• Employed at the Department for Child and Adolescent Mental Health Services at Akershus University Hospital.

Sponsors & Collaborators

• University Hospital, Akershus: lead

Study Sites (1)

Akershus universitetssykehus

Viken, Norway

Location

MeSH Terms

Conditions

Psychotic Disorders; Bipolar Disorder

Interventions

Salvage Therapy

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic Disorders; Mental Disorders; Bipolar and Related Disorders; Mood Disorders

Intervention Hierarchy (Ancestors)

Therapeutics

Study Officials

• Anne-Lise Holmesland, PhD

  University Hospital, Akershus

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: OTHER
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Prinsipal investigator

Study Record Dates

• First Submitted: February 14, 2021
• First Posted: March 2, 2021
• Study Start: March 9, 2021
• Primary Completion: June 30, 2022
• Study Completion: June 30, 2022
• Last Updated: September 30, 2022

Record last verified: 2022-09

Data Sharing

• IPD Sharing: Will not share

Locations

NO (1)